Cargando…

Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment

BACKGROUND: Hepatitis C virus (HCV) infection affects lipid metabolism. We investigated the impact of direct-acting antiviral (DAA) treatment on lipid metabolism in chronic hepatitis C (CHC), with a focus on the effects of anthropometric parameters and liver histology. We also analyzed the dynamics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iossa, Domenico, Vitrone, Martina, Gagliardi, Massimo, Falco, Erasmo, Ragone, Enrico, Zampino, Rosa, Durante-Mangoni, Emanuele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859777/ https://www.ncbi.nlm.nih.gov/pubmed/33553328 http://dx.doi.org/10.21037/atm-20-669

Ejemplares similares

Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
por: Ramadan, Mohammad Said, et al.
Publicado: (2022)

Effects of Direct-Acting Antiviral Agents on the Mental Health of Patients with Chronic Hepatitis C: A Prospective Observational Study
por: Fabrazzo, Michele, et al.
Publicado: (2020)

Clinical Significance and Prognostic Value of Hemostasis Parameters in 337 Patients with Acute Infective Endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

Does this patient have COVID-19? A practical guide for the internist
por: Bertolino, Lorenzo, et al.
Publicado: (2020)

Early viral kinetics and response to treatment in a hepatitis C virus genotype 5 infected patient
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2011)

Infection of Retained Defibrillator Lead Fragment after Heart Transplant
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2017)

Incidence, Risk Factors and Clinical Implications of Glucose Metabolic Changes after Heart Transplant
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2022)

Effect of a Cooperation Strategy between Primary Care Physicians and Hospital Liver Units on HBV Care in Campania, Italy
por: Zampino, Rosa, et al.
Publicado: (2018)

Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis
por: Zampino, Rosa, et al.
Publicado: (2021)

Risk Factors and Outcome of Multidrug-Resistant Infections after Heart Transplant: A Contemporary Single Center Experience
por: Karruli, Arta, et al.
Publicado: (2021)

Dissecting the correlates of N-terminal prohormone brain natriuretic peptide in acute infective endocarditis
por: Bertolino, Lorenzo, et al.
Publicado: (2022)

Prognostic Value of Decreased High-Density Lipoprotein Cholesterol Levels in Infective Endocarditis
por: Zampino, Rosa, et al.
Publicado: (2022)

Real-Life Early Anthropometric, Lipid and Liver Changes after Direct-Acting Antiviral Therapy in PLWHIV with HCV Co-Infection
por: Ferra-Murcia, Sergio, et al.
Publicado: (2022)

Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series
por: Patauner, Fabian, et al.
Publicado: (2022)

HIV/HCV Antiviral Drug Interactions in the Era of Direct-acting Antivirals
por: Rice, Donald P., et al.
Publicado: (2016)

Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review
por: Ramadan, Mohammad Said, et al.
Publicado: (2021)

Infective endocarditis involving MitraClip(©) devices: a systematic literature review
por: Bertolino, Lorenzo, et al.
Publicado: (2023)

Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C
por: Boccia, Filomena, et al.
Publicado: (2023)

Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients
por: Armando, Calogero, et al.
Publicado: (2019)

HCV-Associated Nephropathies in the Era of Direct Acting Antiviral Agents
por: Angeletti, Andrea, et al.
Publicado: (2019)

The ‘Viennese epidemic’ of acute HCV in the era of direct‐acting antivirals
por: Chromy, David, et al.
Publicado: (2022)

Transplantation of HCV Viremic Livers into HCV Viremic Recipients Followed by Direct-acting Antiviral Therapy
por: Kapila, Nikhil, et al.
Publicado: (2019)

Long-Term Outcome of Infective Endocarditis Involving Cardiac Implantable Electronic Devices: Impact of Comorbidities and Lead Extraction
por: Durante-Mangoni, Emanuele, et al.
Publicado: (2022)

Erratum to “Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients”
por: Calogero, Armando, et al.
Publicado: (2019)

Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
por: Dold, L., et al.
Publicado: (2019)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
por: Stevenson, Heather L., et al.
Publicado: (2016)

Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation
por: Martin, Natasha K., et al.
Publicado: (2016)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
por: Minosse, Claudia, et al.
Publicado: (2021)

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients
por: Gambato, Martina, et al.
Publicado: (2023)

Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective
por: Ramadan, Mohammad Said, et al.
Publicado: (2021)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Baseline Plasma Metabotype Correlates With Direct-Acting Antiviral Therapy Nonresponse for HCV in HIV–HCV Coinfected Patients
por: Tripathi, Gaurav, et al.
Publicado: (2022)

Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank
por: Kliemann, Dimas Alexandre, et al.
Publicado: (2016)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
por: La Manna, Gaetano
Publicado: (2018)

Direct-Acting Antiviral Agents for HCV-Associated Glomerular Disease and the Current Evidence
por: Fabrizi, Fabrizio, et al.
Publicado: (2019)

Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCV
por: Patel, Sonia Vibhakar, et al.
Publicado: (2020)

356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment
por: Michienzi, Sarah M, et al.
Publicado: (2019)

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy
por: Auma, Ann W N, et al.
Publicado: (2021)

HIV tropism switch in archived DNA of HIV-HCV subjects successfully treated with direct-acting antivirals for HCV infection
por: Basso, Monica, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7k02uhfjm3i08tm23l6frdvlir